EEG-based DIagnosis Support solutiON (EDISON) to help close the epilepsy diagnos...
EEG-based DIagnosis Support solutiON (EDISON) to help close the epilepsy diagnosis gap in Low- and Middle-Income Countries (LMICs) by combining low CAPEX and AI-guided capture with telemedic
About 40M people in low- and middle-income countries (LMIC) suffer from epilepsy-related seizures but not all are diagnosed and treated due to the lack of electroencephalogram (EEG) devices and neurologists in these regions.
Brain...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
PID2020-119072RA-I00
DESARROLLO DE UN SISTEMA CLINICO DE MONITORIZACION EN TIEMPO...
121K€
Cerrado
BabyMinder
BabyMinder Automatic diagnosis of neurocognitive impairment...
150K€
Cerrado
EpiGrid
EpiGrid: Soft and flexible high density electrode grids for...
150K€
Cerrado
Información proyecto EDISON
Duración del proyecto: 22 meses
Fecha Inicio: 2022-07-27
Fecha Fin: 2024-05-31
Líder del proyecto
BRAINCAPTURE APS
No se ha especificado una descripción o un objeto social para esta compañía.
Presupuesto del proyecto
3M€
Descripción del proyecto
About 40M people in low- and middle-income countries (LMIC) suffer from epilepsy-related seizures but not all are diagnosed and treated due to the lack of electroencephalogram (EEG) devices and neurologists in these regions.
BrainCapture (BC) is developing an EEG-based diagnosis service (BrainCap) for epilepsy and other neurological disorders that fits LMIC needs since it is affordable, uses mobile phone infrastructure and does not need an EEG expert on-site for data capture due to an AI-based Quality Control (QC) algorithm. Data is analysed by remotely placed neurologists who provide a diagnosis and treatment plan via the BrainCap app/cloud.
Our field trials revealed that there is a clinical need for BrainCap. Now, we will finish the product design, optimize the QC algorithm, and extend clinical validation to multiple sites to convince KOLs in several primary markets. The EIC investment will be key to create EEG market in LMICs, leveraging a significant business opportunity for BC.